Related Experiment Video
Updated: Jun 15, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr Virus in the Cerebrospinal Fluid and Blood Compartments of Patients With Multiple Sclerosis and Controls
Joonas Lehikoinen1, Katariina Nurmi1, Mari Ainola1
1From the Translational Immunology Research Program (J.L., K.N., M.A., J.K.N., L.J., S.M.L., K.K.E., P.J.T.), University of Helsinki; Departments of Neurology (J.L., J.K.N., L.J., S.M.L., P.J.T.), Neurocenter, and Rheumatology (K.N., M.A., K.K.E.), Helsinki University Hospital; Research and Development (J.C.), Finnish Red Cross Blood Service, Helsinki; and Department of Virology (H.V., A.V., T.S.), Medicum, University of Helsinki, Finland.
Background And Objectives:
Epstein-Barr virus (EBV) infection is a major risk factor of multiple sclerosis (MS). We examined the presence of EBV DNA in the CSF and blood of patients with MS and controls. We analyzed whether EBV DNA is more common in the CSF of patients with MS than in controls and estimated the proportions of EBV-positive B cells in the CSF and blood.
Methods:
CSF supernatants and cells were collected at diagnostic lumbar punctures from 45 patients with MS and 45 HLA-DR15 matched controls with other conditions, all participants were EBV seropositive. Cellular DNA was amplified by Phi polymerase targeting both host and viral DNA, and representative samples were obtained in 28 cases and 28 controls. Nonamplified DNA from CSF cells (14 cases, 14 controls) and blood B cells (10 cases, 10 controls) were analyzed in a subset of participants. Multiple droplet digital PCR (ddPCR) runs were performed per sample to assess the cumulative EBV positivity rate. To detect viral RNA as a sign of activation, RNA sequencing was performed in blood CD4-positive, CD8-positive, and CD19-positive cells from 21 patients with MS and 3 controls.
Results:
One of the 45 patients with MS and none of the 45 controls were positive for EBV DNA in CSF supernatants (1 mL). CSF cellular DNA was analyzed in 8 independent ddPCRs: EBV DNA was detected at least once in 18 (64%) of the 28 patients with MS and in 15 (54%) of the 28 controls (p = 0.59, Fisher test). The cumulative EBV positivity increased steadily up to 59% in the successive ddPCRs, suggesting that all individuals would have reached EBV positivity in the CSF cells, if more DNA would have been analyzed. The estimated proportion of EBV-positive B cells was >1/10,000 in both the CSF and blood. We did not detect viral RNA, except from endogenous retroviruses, in the blood lymphocyte subpopulations.
Discussion:
EBV-DNA is equally detectable in the CSF cells of both patients with MS and controls with ddPCR, and the probabilistic approach indicates that the true positivity rate approaches 100% in EBV-positive individuals. The proportion of EBV-positive B cells seems higher than previously estimated.
Insights
Epstein-Barr virus (EBV) DNA is equally detectable in cerebrospinal fluid (CSF) cells of multiple sclerosis (MS) patients and controls. The proportion of EBV-positive B cells in CSF and blood may be higher than previously thought.
Area of Science:
- Neuroimmunology
- Virology
- Molecular Biology
Background:
- Epstein-Barr virus (EBV) infection is a significant risk factor for multiple sclerosis (MS).
- This study investigates the presence and prevalence of EBV DNA in the cerebrospinal fluid (CSF) and blood of MS patients and controls.
Purpose of the Study:
- To determine if EBV DNA is more common in the CSF of MS patients compared to controls.
- To estimate the proportions of EBV-positive B cells in both CSF and blood.
Main Methods:
- Collected CSF and blood samples from 45 MS patients and 45 matched controls, all EBV seropositive.
- Utilized multiple droplet digital PCR (ddPCR) to detect EBV DNA in CSF cells and blood B cells.
- Performed RNA sequencing on blood lymphocyte subpopulations to detect viral RNA as a sign of activation.
Main Results:
- EBV DNA was detected in CSF cells of 64% of MS patients and 54% of controls (p=0.59).
- A probabilistic approach suggests near 100% EBV positivity in CSF cells of EBV-seropositive individuals.
- The estimated proportion of EBV-positive B cells in CSF and blood exceeded 1/10,000.
Conclusions:
- EBV DNA detection in CSF cells using ddPCR is similar between MS patients and controls.
- The true EBV positivity rate in CSF cells approaches 100% in EBV-seropositive individuals.
- The prevalence of EBV-positive B cells may be underestimated by previous studies.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Arboviral Encephalitis
Viral Meningitis